Sterling Chemicals

Sterling Pharma Solutions is a global contract development and manufacturing organization (CDMO) specializing in complex small molecule APIs and intermediates for the pharmaceutical and biotechnology industries. The company provides a full suite of services ranging from early-stage discovery and process development to commercial-scale production and packaging. Sterling is recognized for its expertise in hazardous chemistry, high-potency APIs (HPAPIs), and its expanding capabilities in antibody-drug conjugate (ADC) development following the acquisition of ADC Bio. Headquartered in the United Kingdom, Sterling operates a network of cGMP-compliant facilities across Europe and North America, supporting a diverse global client base. The company's focus on service excellence and its integrated approach to the product lifecycle make it a key partner for both emerging biotechs and large pharmaceutical companies.